nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—VEGFA—asthma	0.186	0.473	CbGaD
Vandetanib—EGFR—asthma	0.157	0.399	CbGaD
Vandetanib—ALB—asthma	0.0499	0.127	CbGaD
Vandetanib—ABCG2—Zafirlukast—asthma	0.0271	0.154	CbGbCtD
Vandetanib—ABCG2—Hydrocortisone—asthma	0.011	0.0626	CbGbCtD
Vandetanib—CYP3A4—Fluticasone furoate—asthma	0.00985	0.0558	CbGbCtD
Vandetanib—CYP3A4—Budesonide—asthma	0.00878	0.0498	CbGbCtD
Vandetanib—CYP3A4—Ciclesonide—asthma	0.00803	0.0455	CbGbCtD
Vandetanib—CYP3A4—Indacaterol—asthma	0.00803	0.0455	CbGbCtD
Vandetanib—ALB—Prednisone—asthma	0.00758	0.043	CbGbCtD
Vandetanib—CYP3A4—Salmeterol—asthma	0.00746	0.0423	CbGbCtD
Vandetanib—CYP3A4—Salbutamol—asthma	0.00746	0.0423	CbGbCtD
Vandetanib—CYP3A4—Flunisolide—asthma	0.00746	0.0423	CbGbCtD
Vandetanib—FMO3—sweat—asthma	0.00735	0.0789	CbGeAlD
Vandetanib—ABCG2—Dexamethasone—asthma	0.00686	0.0389	CbGbCtD
Vandetanib—CYP3A4—Zileuton—asthma	0.00665	0.0377	CbGbCtD
Vandetanib—CYP3A4—Ipratropium bromide—asthma	0.00665	0.0377	CbGbCtD
Vandetanib—CYP3A4—Fluticasone Propionate—asthma	0.00635	0.036	CbGbCtD
Vandetanib—CYP3A4—Zafirlukast—asthma	0.00586	0.0332	CbGbCtD
Vandetanib—CYP3A4—Tiotropium—asthma	0.00504	0.0286	CbGbCtD
Vandetanib—CYP3A4—Aminophylline—asthma	0.00481	0.0273	CbGbCtD
Vandetanib—CYP3A4—Theophylline—asthma	0.00452	0.0256	CbGbCtD
Vandetanib—CYP3A4—Montelukast—asthma	0.00429	0.0243	CbGbCtD
Vandetanib—CYP3A4—Loratadine—asthma	0.00429	0.0243	CbGbCtD
Vandetanib—CYP3A4—Methylprednisolone—asthma	0.00392	0.0222	CbGbCtD
Vandetanib—CYP3A4—Triamcinolone—asthma	0.00297	0.0169	CbGbCtD
Vandetanib—RET—autonomic nervous system—asthma	0.00266	0.0285	CbGeAlD
Vandetanib—CYP3A4—Betamethasone—asthma	0.00255	0.0145	CbGbCtD
Vandetanib—CYP3A4—Prednisolone—asthma	0.00252	0.0143	CbGbCtD
Vandetanib—CYP3A4—Hydrocortisone—asthma	0.00238	0.0135	CbGbCtD
Vandetanib—CYP3A4—Prednisone—asthma	0.00238	0.0135	CbGbCtD
Vandetanib—Bosutinib—CDK2—asthma	0.00161	0.396	CrCbGaD
Vandetanib—ORM1—saliva—asthma	0.00157	0.0168	CbGeAlD
Vandetanib—CYP3A4—Dexamethasone—asthma	0.00148	0.00841	CbGbCtD
Vandetanib—ERBB3—exocrine gland—asthma	0.00142	0.0152	CbGeAlD
Vandetanib—PLK4—respiratory system—asthma	0.00107	0.0115	CbGeAlD
Vandetanib—PTK6—bronchus—asthma	0.00107	0.0114	CbGeAlD
Vandetanib—MAP3K19—respiratory system—asthma	0.000982	0.0105	CbGeAlD
Vandetanib—PTK6—trachea—asthma	0.000958	0.0103	CbGeAlD
Vandetanib—FLT3—respiratory system—asthma	0.000853	0.00915	CbGeAlD
Vandetanib—Afatinib—EGFR—asthma	0.000833	0.205	CrCbGaD
Vandetanib—BLK—adrenal gland—asthma	0.000828	0.00889	CbGeAlD
Vandetanib—BMPR1B—epithelium—asthma	0.000821	0.00881	CbGeAlD
Vandetanib—BMPR1B—bronchus—asthma	0.000808	0.00867	CbGeAlD
Vandetanib—FLT4—respiratory system—asthma	0.000774	0.00831	CbGeAlD
Vandetanib—ERBB3—respiratory system—asthma	0.000737	0.00791	CbGeAlD
Vandetanib—LTK—lung—asthma	0.000718	0.0077	CbGeAlD
Vandetanib—VEGFA—Glyburide—Zafirlukast—asthma	0.000717	0.232	CbGdCrCtD
Vandetanib—PTK6—lung—asthma	0.000688	0.00739	CbGeAlD
Vandetanib—FGR—respiratory system—asthma	0.000684	0.00734	CbGeAlD
Vandetanib—AXL—respiratory system—asthma	0.000681	0.00731	CbGeAlD
Vandetanib—FMO3—respiratory system—asthma	0.00066	0.00708	CbGeAlD
Vandetanib—FLT3—cardiovascular system—asthma	0.000653	0.00701	CbGeAlD
Vandetanib—FLT4—adrenal cortex—asthma	0.00065	0.00697	CbGeAlD
Vandetanib—FLT4—epithelium—asthma	0.000647	0.00694	CbGeAlD
Vandetanib—PLK4—adrenal gland—asthma	0.000647	0.00694	CbGeAlD
Vandetanib—VEGFA—adrenal cortex—asthma	0.000645	0.00692	CbGeAlD
Vandetanib—RIPK2—epithelium—asthma	0.000644	0.00691	CbGeAlD
Vandetanib—FYN—respiratory system—asthma	0.000637	0.00684	CbGeAlD
Vandetanib—RIPK2—bronchus—asthma	0.000634	0.0068	CbGeAlD
Vandetanib—VEGFA—bronchus—asthma	0.000632	0.00678	CbGeAlD
Vandetanib—IRAK4—adrenal cortex—asthma	0.000631	0.00677	CbGeAlD
Vandetanib—TEK—respiratory system—asthma	0.000623	0.00668	CbGeAlD
Vandetanib—IRAK4—bronchus—asthma	0.000619	0.00664	CbGeAlD
Vandetanib—VEGFA—smooth muscle tissue—asthma	0.000618	0.00664	CbGeAlD
Vandetanib—ERBB3—epithelium—asthma	0.000616	0.00661	CbGeAlD
Vandetanib—BMPR1B—adrenal gland—asthma	0.000595	0.00639	CbGeAlD
Vandetanib—FLT4—cardiovascular system—asthma	0.000593	0.00636	CbGeAlD
Vandetanib—RIPK2—cardiovascular system—asthma	0.00059	0.00633	CbGeAlD
Vandetanib—Erlotinib—EGFR—asthma	0.000588	0.145	CrCbGaD
Vandetanib—MKNK1—adrenal cortex—asthma	0.000581	0.00623	CbGeAlD
Vandetanib—YES1—respiratory system—asthma	0.000575	0.00617	CbGeAlD
Vandetanib—AXL—adrenal cortex—asthma	0.000571	0.00613	CbGeAlD
Vandetanib—RET—epithelium—asthma	0.000571	0.00613	CbGeAlD
Vandetanib—STK10—respiratory system—asthma	0.00057	0.00612	CbGeAlD
Vandetanib—MKNK1—bronchus—asthma	0.00057	0.00611	CbGeAlD
Vandetanib—RIPK2—trachea—asthma	0.000569	0.00611	CbGeAlD
Vandetanib—VEGFA—trachea—asthma	0.000568	0.00609	CbGeAlD
Vandetanib—PLK4—lung—asthma	0.000567	0.00608	CbGeAlD
Vandetanib—FMO1—trachea—asthma	0.000565	0.00606	CbGeAlD
Vandetanib—LCK—bronchus—asthma	0.000563	0.00604	CbGeAlD
Vandetanib—IRAK4—trachea—asthma	0.000556	0.00596	CbGeAlD
Vandetanib—FMO3—adrenal cortex—asthma	0.000554	0.00595	CbGeAlD
Vandetanib—SRC—respiratory system—asthma	0.000553	0.00594	CbGeAlD
Vandetanib—SLK—adrenal cortex—asthma	0.00055	0.0059	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—asthma	0.000548	0.00588	CbGeAlD
Vandetanib—ERBB3—trachea—asthma	0.000545	0.00585	CbGeAlD
Vandetanib—FMO3—bronchus—asthma	0.000543	0.00583	CbGeAlD
Vandetanib—SLK—bronchus—asthma	0.000539	0.00579	CbGeAlD
Vandetanib—MKNK1—cardiovascular system—asthma	0.00053	0.00569	CbGeAlD
Vandetanib—FYN—bronchus—asthma	0.000524	0.00563	CbGeAlD
Vandetanib—FGR—cardiovascular system—asthma	0.000524	0.00562	CbGeAlD
Vandetanib—TEK—adrenal cortex—asthma	0.000523	0.00561	CbGeAlD
Vandetanib—BMPR1B—lung—asthma	0.000522	0.0056	CbGeAlD
Vandetanib—MAP3K19—lung—asthma	0.000522	0.0056	CbGeAlD
Vandetanib—AXL—cardiovascular system—asthma	0.000522	0.0056	CbGeAlD
Vandetanib—TEK—epithelium—asthma	0.00052	0.00558	CbGeAlD
Vandetanib—FLT3—adrenal gland—asthma	0.000517	0.00554	CbGeAlD
Vandetanib—FYN—smooth muscle tissue—asthma	0.000513	0.00551	CbGeAlD
Vandetanib—TEK—bronchus—asthma	0.000513	0.0055	CbGeAlD
Vandetanib—MAP4K5—bronchus—asthma	0.000513	0.0055	CbGeAlD
Vandetanib—KDR—respiratory system—asthma	0.000509	0.00546	CbGeAlD
Vandetanib—STK35—adrenal gland—asthma	0.000506	0.00543	CbGeAlD
Vandetanib—LCK—trachea—asthma	0.000505	0.00542	CbGeAlD
Vandetanib—AXL—trachea—asthma	0.000503	0.0054	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—asthma	0.000501	0.00538	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—asthma	0.000501	0.00538	CbGeAlD
Vandetanib—ABL2—adrenal gland—asthma	0.000493	0.00529	CbGeAlD
Vandetanib—EPHB6—bronchus—asthma	0.00049	0.00526	CbGeAlD
Vandetanib—FYN—cardiovascular system—asthma	0.000488	0.00524	CbGeAlD
Vandetanib—SLK—trachea—asthma	0.000484	0.0052	CbGeAlD
Vandetanib—YES1—adrenal cortex—asthma	0.000483	0.00518	CbGeAlD
Vandetanib—EGFR—adrenal gland—asthma	0.000481	0.00516	CbGeAlD
Vandetanib—TEK—cardiovascular system—asthma	0.000477	0.00512	CbGeAlD
Vandetanib—YES1—bronchus—asthma	0.000473	0.00508	CbGeAlD
Vandetanib—FYN—trachea—asthma	0.000471	0.00505	CbGeAlD
Vandetanib—FLT4—adrenal gland—asthma	0.000469	0.00503	CbGeAlD
Vandetanib—STK10—bronchus—asthma	0.000469	0.00503	CbGeAlD
Vandetanib—RIPK2—adrenal gland—asthma	0.000467	0.00501	CbGeAlD
Vandetanib—VEGFA—adrenal gland—asthma	0.000465	0.00499	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—asthma	0.000463	0.00497	CbGeAlD
Vandetanib—FMO1—adrenal gland—asthma	0.000463	0.00497	CbGeAlD
Vandetanib—SRC—epithelium—asthma	0.000462	0.00496	CbGeAlD
Vandetanib—MAP4K5—trachea—asthma	0.00046	0.00494	CbGeAlD
Vandetanib—IRAK4—adrenal gland—asthma	0.000456	0.00489	CbGeAlD
Vandetanib—FLT3—lung—asthma	0.000453	0.00486	CbGeAlD
Vandetanib—SRC—smooth muscle tissue—asthma	0.000446	0.00478	CbGeAlD
Vandetanib—STK35—lung—asthma	0.000444	0.00476	CbGeAlD
Vandetanib—PDGFRB—respiratory system—asthma	0.000441	0.00473	CbGeAlD
Vandetanib—EPHB6—trachea—asthma	0.00044	0.00472	CbGeAlD
Vandetanib—STK10—cardiovascular system—asthma	0.000437	0.00468	CbGeAlD
Vandetanib—ABL2—lung—asthma	0.000432	0.00464	CbGeAlD
Vandetanib—MAP2K5—adrenal cortex—asthma	0.000427	0.00458	CbGeAlD
Vandetanib—KDR—adrenal cortex—asthma	0.000427	0.00458	CbGeAlD
Vandetanib—KDR—epithelium—asthma	0.000425	0.00456	CbGeAlD
Vandetanib—YES1—trachea—asthma	0.000425	0.00456	CbGeAlD
Vandetanib—SRC—cardiovascular system—asthma	0.000424	0.00455	CbGeAlD
Vandetanib—EGFR—lung—asthma	0.000422	0.00453	CbGeAlD
Vandetanib—MKNK1—adrenal gland—asthma	0.000419	0.0045	CbGeAlD
Vandetanib—KDR—bronchus—asthma	0.000419	0.00449	CbGeAlD
Vandetanib—MAP2K5—bronchus—asthma	0.000419	0.00449	CbGeAlD
Vandetanib—FGR—adrenal gland—asthma	0.000414	0.00444	CbGeAlD
Vandetanib—RET—adrenal gland—asthma	0.000414	0.00444	CbGeAlD
Vandetanib—LCK—adrenal gland—asthma	0.000414	0.00444	CbGeAlD
Vandetanib—AXL—adrenal gland—asthma	0.000413	0.00443	CbGeAlD
Vandetanib—FLT4—lung—asthma	0.000411	0.00441	CbGeAlD
Vandetanib—KDR—smooth muscle tissue—asthma	0.00041	0.0044	CbGeAlD
Vandetanib—RIPK2—lung—asthma	0.000409	0.00439	CbGeAlD
Vandetanib—VEGFA—lung—asthma	0.000408	0.00438	CbGeAlD
Vandetanib—FMO1—lung—asthma	0.000406	0.00435	CbGeAlD
Vandetanib—FMO3—adrenal gland—asthma	0.0004	0.00429	CbGeAlD
Vandetanib—IRAK4—lung—asthma	0.000399	0.00428	CbGeAlD
Vandetanib—SLK—adrenal gland—asthma	0.000397	0.00426	CbGeAlD
Vandetanib—ABL1—respiratory system—asthma	0.000393	0.00421	CbGeAlD
Vandetanib—ERBB3—lung—asthma	0.000391	0.0042	CbGeAlD
Vandetanib—MAP2K5—cardiovascular system—asthma	0.00039	0.00418	CbGeAlD
Vandetanib—KDR—cardiovascular system—asthma	0.00039	0.00418	CbGeAlD
Vandetanib—FYN—adrenal gland—asthma	0.000386	0.00414	CbGeAlD
Vandetanib—TEK—adrenal gland—asthma	0.000377	0.00405	CbGeAlD
Vandetanib—MAP4K5—adrenal gland—asthma	0.000377	0.00405	CbGeAlD
Vandetanib—MAP2K5—trachea—asthma	0.000376	0.00404	CbGeAlD
Vandetanib—KDR—trachea—asthma	0.000376	0.00404	CbGeAlD
Vandetanib—PDGFRB—adrenal cortex—asthma	0.00037	0.00397	CbGeAlD
Vandetanib—PDGFRB—epithelium—asthma	0.000368	0.00395	CbGeAlD
Vandetanib—Gefitinib—EGFR—asthma	0.000368	0.0905	CrCbGaD
Vandetanib—MKNK1—lung—asthma	0.000367	0.00394	CbGeAlD
Vandetanib—LCK—lung—asthma	0.000363	0.0039	CbGeAlD
Vandetanib—FGR—lung—asthma	0.000363	0.0039	CbGeAlD
Vandetanib—PDGFRB—bronchus—asthma	0.000363	0.00389	CbGeAlD
Vandetanib—Bosutinib—EGFR—asthma	0.000362	0.0891	CrCbGaD
Vandetanib—AXL—lung—asthma	0.000362	0.00388	CbGeAlD
Vandetanib—EPHB6—adrenal gland—asthma	0.000361	0.00387	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—asthma	0.000355	0.00381	CbGeAlD
Vandetanib—FMO3—lung—asthma	0.000351	0.00376	CbGeAlD
Vandetanib—YES1—adrenal gland—asthma	0.000348	0.00374	CbGeAlD
Vandetanib—SLK—lung—asthma	0.000348	0.00373	CbGeAlD
Vandetanib—STK10—adrenal gland—asthma	0.000345	0.0037	CbGeAlD
Vandetanib—MKNK1—Pindolol—Isoprenaline—asthma	0.000345	0.111	CbGdCrCtD
Vandetanib—FYN—lung—asthma	0.000338	0.00363	CbGeAlD
Vandetanib—PDGFRB—cardiovascular system—asthma	0.000337	0.00362	CbGeAlD
Vandetanib—SRC—adrenal gland—asthma	0.000335	0.0036	CbGeAlD
Vandetanib—MAP4K5—lung—asthma	0.000331	0.00355	CbGeAlD
Vandetanib—TEK—lung—asthma	0.000331	0.00355	CbGeAlD
Vandetanib—ABL1—adrenal cortex—asthma	0.00033	0.00354	CbGeAlD
Vandetanib—PDGFRB—trachea—asthma	0.000326	0.00349	CbGeAlD
Vandetanib—ABL1—bronchus—asthma	0.000323	0.00347	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—asthma	0.000316	0.00339	CbGeAlD
Vandetanib—EPHB6—lung—asthma	0.000316	0.00339	CbGeAlD
Vandetanib—ERBB3—Methyldopa—Isoetarine—asthma	0.000311	0.1	CbGdCrCtD
Vandetanib—KDR—adrenal gland—asthma	0.000308	0.00331	CbGeAlD
Vandetanib—MAP2K5—adrenal gland—asthma	0.000308	0.00331	CbGeAlD
Vandetanib—YES1—lung—asthma	0.000305	0.00328	CbGeAlD
Vandetanib—STK10—lung—asthma	0.000303	0.00325	CbGeAlD
Vandetanib—ABL1—cardiovascular system—asthma	0.000301	0.00323	CbGeAlD
Vandetanib—SRC—lung—asthma	0.000294	0.00315	CbGeAlD
Vandetanib—ABL1—trachea—asthma	0.00029	0.00311	CbGeAlD
Vandetanib—KDR—lung—asthma	0.00027	0.0029	CbGeAlD
Vandetanib—MAP2K5—lung—asthma	0.00027	0.0029	CbGeAlD
Vandetanib—PDGFRB—adrenal gland—asthma	0.000267	0.00286	CbGeAlD
Vandetanib—ABCC1—adrenal cortex—asthma	0.000251	0.00269	CbGeAlD
Vandetanib—ABCC1—bronchus—asthma	0.000246	0.00264	CbGeAlD
Vandetanib—ABL1—adrenal gland—asthma	0.000238	0.00255	CbGeAlD
Vandetanib—ERBB3—Methyldopa—Isoprenaline—asthma	0.000236	0.076	CbGdCrCtD
Vandetanib—PDGFRB—lung—asthma	0.000234	0.00251	CbGeAlD
Vandetanib—ABCC1—trachea—asthma	0.000221	0.00237	CbGeAlD
Vandetanib—ALB—adrenal gland—asthma	0.00022	0.00236	CbGeAlD
Vandetanib—ORM1—lung—asthma	0.000219	0.00235	CbGeAlD
Vandetanib—ABL1—lung—asthma	0.000208	0.00224	CbGeAlD
Vandetanib—ABCG2—adrenal cortex—asthma	0.000208	0.00223	CbGeAlD
Vandetanib—VEGFA—Pindolol—Isoprenaline—asthma	0.000198	0.064	CbGdCrCtD
Vandetanib—Erlotinib—ALB—asthma	0.000187	0.0461	CrCbGaD
Vandetanib—ABCC1—adrenal gland—asthma	0.000181	0.00194	CbGeAlD
Vandetanib—ABCC1—lung—asthma	0.000159	0.0017	CbGeAlD
Vandetanib—ABCG2—adrenal gland—asthma	0.00015	0.00161	CbGeAlD
Vandetanib—ABCG2—lung—asthma	0.000131	0.00141	CbGeAlD
Vandetanib—Gefitinib—ALB—asthma	0.000117	0.0288	CrCbGaD
Vandetanib—VEGFA—Betamethasone—Fluticasone furoate—asthma	0.000102	0.0331	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Fluticasone furoate—asthma	0.000102	0.0331	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Fluticasone Propionate—asthma	9.56e-05	0.0309	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Fluticasone Propionate—asthma	9.56e-05	0.0309	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Beclomethasone—asthma	7.02e-05	0.0227	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Beclomethasone—asthma	7.02e-05	0.0227	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Budesonide—asthma	6.73e-05	0.0217	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Budesonide—asthma	6.73e-05	0.0217	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Flunisolide—asthma	6.65e-05	0.0215	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Flunisolide—asthma	6.65e-05	0.0215	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Mometasone—asthma	5.45e-05	0.0176	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Mometasone—asthma	5.45e-05	0.0176	CbGdCrCtD
Vandetanib—Dizziness—Formoterol—asthma	4.59e-05	0.000261	CcSEcCtD
Vandetanib—Asthenia—Budesonide—asthma	4.56e-05	0.000259	CcSEcCtD
Vandetanib—Eye disorder—Methylprednisolone—asthma	4.54e-05	0.000258	CcSEcCtD
Vandetanib—Mental disorder—Hydrocortisone—asthma	4.53e-05	0.000258	CcSEcCtD
Vandetanib—Cardiac disorder—Methylprednisolone—asthma	4.51e-05	0.000257	CcSEcCtD
Vandetanib—Malnutrition—Hydrocortisone—asthma	4.5e-05	0.000256	CcSEcCtD
Vandetanib—Dizziness—Montelukast—asthma	4.5e-05	0.000256	CcSEcCtD
Vandetanib—Bradycardia—Betamethasone—asthma	4.5e-05	0.000256	CcSEcCtD
Vandetanib—Bradycardia—Dexamethasone—asthma	4.5e-05	0.000256	CcSEcCtD
Vandetanib—Neutropenia—Prednisone—asthma	4.49e-05	0.000256	CcSEcCtD
Vandetanib—Pruritus—Budesonide—asthma	4.49e-05	0.000256	CcSEcCtD
Vandetanib—Diarrhoea—Salbutamol—asthma	4.49e-05	0.000255	CcSEcCtD
Vandetanib—Haemoglobin—Dexamethasone—asthma	4.44e-05	0.000253	CcSEcCtD
Vandetanib—Haemoglobin—Betamethasone—asthma	4.44e-05	0.000253	CcSEcCtD
Vandetanib—Haemorrhage—Dexamethasone—asthma	4.42e-05	0.000251	CcSEcCtD
Vandetanib—Haemorrhage—Betamethasone—asthma	4.42e-05	0.000251	CcSEcCtD
Vandetanib—Vomiting—Formoterol—asthma	4.41e-05	0.000251	CcSEcCtD
Vandetanib—Vomiting—Arformoterol—asthma	4.41e-05	0.000251	CcSEcCtD
Vandetanib—Angiopathy—Methylprednisolone—asthma	4.41e-05	0.000251	CcSEcCtD
Vandetanib—Nausea—Mometasone—asthma	4.39e-05	0.00025	CcSEcCtD
Vandetanib—Rash—Arformoterol—asthma	4.38e-05	0.000249	CcSEcCtD
Vandetanib—Rash—Formoterol—asthma	4.38e-05	0.000249	CcSEcCtD
Vandetanib—Mediastinal disorder—Methylprednisolone—asthma	4.38e-05	0.000249	CcSEcCtD
Vandetanib—Dermatitis—Formoterol—asthma	4.37e-05	0.000249	CcSEcCtD
Vandetanib—Dermatitis—Arformoterol—asthma	4.37e-05	0.000249	CcSEcCtD
Vandetanib—Headache—Formoterol—asthma	4.35e-05	0.000248	CcSEcCtD
Vandetanib—Headache—Arformoterol—asthma	4.35e-05	0.000248	CcSEcCtD
Vandetanib—Arrhythmia—Triamcinolone—asthma	4.35e-05	0.000247	CcSEcCtD
Vandetanib—Weight decreased—Prednisone—asthma	4.35e-05	0.000247	CcSEcCtD
Vandetanib—Diarrhoea—Budesonide—asthma	4.34e-05	0.000247	CcSEcCtD
Vandetanib—Vision blurred—Prednisolone—asthma	4.34e-05	0.000247	CcSEcCtD
Vandetanib—Arrhythmia—Methylprednisolone—asthma	4.34e-05	0.000247	CcSEcCtD
Vandetanib—Dizziness—Salbutamol—asthma	4.34e-05	0.000247	CcSEcCtD
Vandetanib—Hyperglycaemia—Prednisone—asthma	4.33e-05	0.000247	CcSEcCtD
Vandetanib—Vomiting—Montelukast—asthma	4.32e-05	0.000246	CcSEcCtD
Vandetanib—Rash—Montelukast—asthma	4.29e-05	0.000244	CcSEcCtD
Vandetanib—Dermatitis—Montelukast—asthma	4.28e-05	0.000244	CcSEcCtD
Vandetanib—Depression—Prednisone—asthma	4.27e-05	0.000243	CcSEcCtD
Vandetanib—Headache—Montelukast—asthma	4.26e-05	0.000242	CcSEcCtD
Vandetanib—Visual impairment—Betamethasone—asthma	4.26e-05	0.000242	CcSEcCtD
Vandetanib—Visual impairment—Dexamethasone—asthma	4.26e-05	0.000242	CcSEcCtD
Vandetanib—Mental disorder—Methylprednisolone—asthma	4.25e-05	0.000242	CcSEcCtD
Vandetanib—Malnutrition—Methylprednisolone—asthma	4.23e-05	0.000241	CcSEcCtD
Vandetanib—Dizziness—Budesonide—asthma	4.2e-05	0.000239	CcSEcCtD
Vandetanib—Vomiting—Salbutamol—asthma	4.17e-05	0.000237	CcSEcCtD
Vandetanib—Dysgeusia—Triamcinolone—asthma	4.15e-05	0.000236	CcSEcCtD
Vandetanib—Rash—Salbutamol—asthma	4.13e-05	0.000235	CcSEcCtD
Vandetanib—Dermatitis—Salbutamol—asthma	4.13e-05	0.000235	CcSEcCtD
Vandetanib—Eye disorder—Betamethasone—asthma	4.13e-05	0.000235	CcSEcCtD
Vandetanib—Eye disorder—Dexamethasone—asthma	4.13e-05	0.000235	CcSEcCtD
Vandetanib—Nausea—Formoterol—asthma	4.12e-05	0.000235	CcSEcCtD
Vandetanib—Nausea—Arformoterol—asthma	4.12e-05	0.000235	CcSEcCtD
Vandetanib—Headache—Salbutamol—asthma	4.11e-05	0.000234	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisolone—asthma	4.05e-05	0.00023	CcSEcCtD
Vandetanib—Nausea—Montelukast—asthma	4.04e-05	0.00023	CcSEcCtD
Vandetanib—Vomiting—Budesonide—asthma	4.04e-05	0.00023	CcSEcCtD
Vandetanib—Angiopathy—Dexamethasone—asthma	4.01e-05	0.000228	CcSEcCtD
Vandetanib—Angiopathy—Betamethasone—asthma	4.01e-05	0.000228	CcSEcCtD
Vandetanib—Rash—Budesonide—asthma	4e-05	0.000228	CcSEcCtD
Vandetanib—Dermatitis—Budesonide—asthma	4e-05	0.000228	CcSEcCtD
Vandetanib—Convulsion—Prednisolone—asthma	3.99e-05	0.000227	CcSEcCtD
Vandetanib—Headache—Budesonide—asthma	3.98e-05	0.000226	CcSEcCtD
Vandetanib—Hypertension—Prednisolone—asthma	3.98e-05	0.000226	CcSEcCtD
Vandetanib—Loss of consciousness—Hydrocortisone—asthma	3.95e-05	0.000225	CcSEcCtD
Vandetanib—Arrhythmia—Dexamethasone—asthma	3.95e-05	0.000225	CcSEcCtD
Vandetanib—Arrhythmia—Betamethasone—asthma	3.95e-05	0.000225	CcSEcCtD
Vandetanib—Bradycardia—Prednisone—asthma	3.92e-05	0.000223	CcSEcCtD
Vandetanib—Alopecia—Betamethasone—asthma	3.9e-05	0.000222	CcSEcCtD
Vandetanib—Alopecia—Dexamethasone—asthma	3.9e-05	0.000222	CcSEcCtD
Vandetanib—Convulsion—Hydrocortisone—asthma	3.9e-05	0.000222	CcSEcCtD
Vandetanib—Nausea—Salbutamol—asthma	3.89e-05	0.000222	CcSEcCtD
Vandetanib—Hypertension—Hydrocortisone—asthma	3.88e-05	0.000221	CcSEcCtD
Vandetanib—Haemoglobin—Prednisone—asthma	3.87e-05	0.00022	CcSEcCtD
Vandetanib—Haemorrhage—Prednisone—asthma	3.85e-05	0.000219	CcSEcCtD
Vandetanib—Anxiety—Hydrocortisone—asthma	3.82e-05	0.000217	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	3.8e-05	0.000217	CcSEcCtD
Vandetanib—Nausea—Budesonide—asthma	3.77e-05	0.000215	CcSEcCtD
Vandetanib—Oedema—Prednisolone—asthma	3.76e-05	0.000214	CcSEcCtD
Vandetanib—Loss of consciousness—Triamcinolone—asthma	3.72e-05	0.000212	CcSEcCtD
Vandetanib—Loss of consciousness—Methylprednisolone—asthma	3.72e-05	0.000211	CcSEcCtD
Vandetanib—Cough—Triamcinolone—asthma	3.7e-05	0.00021	CcSEcCtD
Vandetanib—Oedema—Hydrocortisone—asthma	3.67e-05	0.000209	CcSEcCtD
Vandetanib—Convulsion—Triamcinolone—asthma	3.67e-05	0.000209	CcSEcCtD
Vandetanib—Convulsion—Methylprednisolone—asthma	3.66e-05	0.000208	CcSEcCtD
Vandetanib—Hypertension—Triamcinolone—asthma	3.66e-05	0.000208	CcSEcCtD
Vandetanib—Hypertension—Methylprednisolone—asthma	3.65e-05	0.000208	CcSEcCtD
Vandetanib—Infection—Hydrocortisone—asthma	3.65e-05	0.000208	CcSEcCtD
Vandetanib—Nervous system disorder—Hydrocortisone—asthma	3.6e-05	0.000205	CcSEcCtD
Vandetanib—Arthralgia—Methylprednisolone—asthma	3.6e-05	0.000205	CcSEcCtD
Vandetanib—Eye disorder—Prednisone—asthma	3.59e-05	0.000205	CcSEcCtD
Vandetanib—Anxiety—Methylprednisolone—asthma	3.59e-05	0.000204	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	3.57e-05	0.000203	CcSEcCtD
Vandetanib—Skin disorder—Hydrocortisone—asthma	3.57e-05	0.000203	CcSEcCtD
Vandetanib—Dry mouth—Triamcinolone—asthma	3.53e-05	0.000201	CcSEcCtD
Vandetanib—Angiopathy—Prednisone—asthma	3.49e-05	0.000199	CcSEcCtD
Vandetanib—Oedema—Triamcinolone—asthma	3.46e-05	0.000197	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Hydrocortisone—asthma	3.45e-05	0.0111	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Hydrocortisone—asthma	3.45e-05	0.0111	CbGdCrCtD
Vandetanib—Arrhythmia—Prednisone—asthma	3.44e-05	0.000196	CcSEcCtD
Vandetanib—Infection—Triamcinolone—asthma	3.44e-05	0.000196	CcSEcCtD
Vandetanib—Infection—Methylprednisolone—asthma	3.43e-05	0.000195	CcSEcCtD
Vandetanib—Insomnia—Prednisolone—asthma	3.4e-05	0.000194	CcSEcCtD
Vandetanib—Alopecia—Prednisone—asthma	3.4e-05	0.000193	CcSEcCtD
Vandetanib—Nervous system disorder—Methylprednisolone—asthma	3.38e-05	0.000193	CcSEcCtD
Vandetanib—Loss of consciousness—Dexamethasone—asthma	3.38e-05	0.000192	CcSEcCtD
Vandetanib—Loss of consciousness—Betamethasone—asthma	3.38e-05	0.000192	CcSEcCtD
Vandetanib—Paraesthesia—Prednisolone—asthma	3.38e-05	0.000192	CcSEcCtD
Vandetanib—Mental disorder—Prednisone—asthma	3.37e-05	0.000192	CcSEcCtD
Vandetanib—Skin disorder—Methylprednisolone—asthma	3.35e-05	0.000191	CcSEcCtD
Vandetanib—Malnutrition—Prednisone—asthma	3.35e-05	0.000191	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Hydrocortisone—asthma	3.35e-05	0.00019	CcSEcCtD
Vandetanib—Convulsion—Betamethasone—asthma	3.33e-05	0.00019	CcSEcCtD
Vandetanib—Convulsion—Dexamethasone—asthma	3.33e-05	0.00019	CcSEcCtD
Vandetanib—Insomnia—Hydrocortisone—asthma	3.32e-05	0.000189	CcSEcCtD
Vandetanib—Hypertension—Betamethasone—asthma	3.32e-05	0.000189	CcSEcCtD
Vandetanib—Hypertension—Dexamethasone—asthma	3.32e-05	0.000189	CcSEcCtD
Vandetanib—Paraesthesia—Hydrocortisone—asthma	3.3e-05	0.000188	CcSEcCtD
Vandetanib—Anxiety—Betamethasone—asthma	3.26e-05	0.000186	CcSEcCtD
Vandetanib—Anxiety—Dexamethasone—asthma	3.26e-05	0.000186	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Methylprednisolone—asthma	3.25e-05	0.0105	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Methylprednisolone—asthma	3.25e-05	0.0105	CbGdCrCtD
Vandetanib—Dyspepsia—Hydrocortisone—asthma	3.23e-05	0.000184	CcSEcCtD
Vandetanib—Pain—Prednisolone—asthma	3.22e-05	0.000183	CcSEcCtD
Vandetanib—VEGFA—Betamethasone—Dexamethasone—asthma	3.2e-05	0.0103	CbGdCrCtD
Vandetanib—VEGFA—Dexamethasone—Betamethasone—asthma	3.2e-05	0.0103	CbGdCrCtD
Vandetanib—Decreased appetite—Hydrocortisone—asthma	3.19e-05	0.000182	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Hydrocortisone—asthma	3.17e-05	0.00018	CcSEcCtD
Vandetanib—Fatigue—Hydrocortisone—asthma	3.17e-05	0.00018	CcSEcCtD
Vandetanib—Vision blurred—Prednisone—asthma	3.16e-05	0.00018	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Triamcinolone—asthma	3.15e-05	0.000179	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Methylprednisolone—asthma	3.14e-05	0.000179	CcSEcCtD
Vandetanib—Pain—Hydrocortisone—asthma	3.14e-05	0.000179	CcSEcCtD
Vandetanib—Oedema—Betamethasone—asthma	3.14e-05	0.000179	CcSEcCtD
Vandetanib—Oedema—Dexamethasone—asthma	3.14e-05	0.000179	CcSEcCtD
Vandetanib—Insomnia—Triamcinolone—asthma	3.13e-05	0.000178	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Triamcinolone—asthma	3.13e-05	0.0101	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Triamcinolone—asthma	3.13e-05	0.0101	CbGdCrCtD
Vandetanib—Insomnia—Methylprednisolone—asthma	3.12e-05	0.000178	CcSEcCtD
Vandetanib—Infection—Dexamethasone—asthma	3.12e-05	0.000177	CcSEcCtD
Vandetanib—Infection—Betamethasone—asthma	3.12e-05	0.000177	CcSEcCtD
Vandetanib—Paraesthesia—Triamcinolone—asthma	3.11e-05	0.000177	CcSEcCtD
Vandetanib—Paraesthesia—Methylprednisolone—asthma	3.1e-05	0.000176	CcSEcCtD
Vandetanib—Dyspnoea—Triamcinolone—asthma	3.08e-05	0.000175	CcSEcCtD
Vandetanib—Nervous system disorder—Dexamethasone—asthma	3.08e-05	0.000175	CcSEcCtD
Vandetanib—Nervous system disorder—Betamethasone—asthma	3.08e-05	0.000175	CcSEcCtD
Vandetanib—Thrombocytopenia—Betamethasone—asthma	3.07e-05	0.000175	CcSEcCtD
Vandetanib—Thrombocytopenia—Dexamethasone—asthma	3.07e-05	0.000175	CcSEcCtD
Vandetanib—Dyspepsia—Triamcinolone—asthma	3.04e-05	0.000173	CcSEcCtD
Vandetanib—Dyspepsia—Methylprednisolone—asthma	3.04e-05	0.000173	CcSEcCtD
Vandetanib—Gastrointestinal pain—Hydrocortisone—asthma	3e-05	0.000171	CcSEcCtD
Vandetanib—Fatigue—Triamcinolone—asthma	2.98e-05	0.00017	CcSEcCtD
Vandetanib—Fatigue—Methylprednisolone—asthma	2.97e-05	0.000169	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Prednisone—asthma	2.97e-05	0.00958	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisone—asthma	2.97e-05	0.00958	CbGdCrCtD
Vandetanib—Pain—Triamcinolone—asthma	2.96e-05	0.000168	CcSEcCtD
Vandetanib—Loss of consciousness—Prednisone—asthma	2.94e-05	0.000167	CcSEcCtD
Vandetanib—Abdominal pain—Hydrocortisone—asthma	2.9e-05	0.000165	CcSEcCtD
Vandetanib—Body temperature increased—Hydrocortisone—asthma	2.9e-05	0.000165	CcSEcCtD
Vandetanib—Convulsion—Prednisone—asthma	2.9e-05	0.000165	CcSEcCtD
Vandetanib—VEGFA—Dexamethasone—Prednisolone—asthma	2.9e-05	0.00935	CbGdCrCtD
Vandetanib—VEGFA—Betamethasone—Prednisolone—asthma	2.9e-05	0.00935	CbGdCrCtD
Vandetanib—Hypertension—Prednisone—asthma	2.89e-05	0.000165	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Betamethasone—asthma	2.86e-05	0.000163	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Dexamethasone—asthma	2.86e-05	0.000163	CcSEcCtD
Vandetanib—Arthralgia—Prednisone—asthma	2.85e-05	0.000162	CcSEcCtD
Vandetanib—Anxiety—Prednisone—asthma	2.84e-05	0.000162	CcSEcCtD
Vandetanib—Insomnia—Dexamethasone—asthma	2.84e-05	0.000162	CcSEcCtD
Vandetanib—Insomnia—Betamethasone—asthma	2.84e-05	0.000162	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.83e-05	0.000161	CcSEcCtD
Vandetanib—Gastrointestinal pain—Methylprednisolone—asthma	2.82e-05	0.000161	CcSEcCtD
Vandetanib—Paraesthesia—Betamethasone—asthma	2.82e-05	0.00016	CcSEcCtD
Vandetanib—Paraesthesia—Dexamethasone—asthma	2.82e-05	0.00016	CcSEcCtD
Vandetanib—Dyspepsia—Betamethasone—asthma	2.76e-05	0.000157	CcSEcCtD
Vandetanib—Dyspepsia—Dexamethasone—asthma	2.76e-05	0.000157	CcSEcCtD
Vandetanib—Body temperature increased—Triamcinolone—asthma	2.73e-05	0.000156	CcSEcCtD
Vandetanib—Oedema—Prednisone—asthma	2.73e-05	0.000156	CcSEcCtD
Vandetanib—Abdominal pain—Methylprednisolone—asthma	2.73e-05	0.000155	CcSEcCtD
Vandetanib—Decreased appetite—Dexamethasone—asthma	2.73e-05	0.000155	CcSEcCtD
Vandetanib—Decreased appetite—Betamethasone—asthma	2.73e-05	0.000155	CcSEcCtD
Vandetanib—Infection—Prednisone—asthma	2.71e-05	0.000154	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Betamethasone—asthma	2.71e-05	0.000154	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Dexamethasone—asthma	2.71e-05	0.000154	CcSEcCtD
Vandetanib—Fatigue—Betamethasone—asthma	2.71e-05	0.000154	CcSEcCtD
Vandetanib—Fatigue—Dexamethasone—asthma	2.71e-05	0.000154	CcSEcCtD
Vandetanib—Pain—Betamethasone—asthma	2.68e-05	0.000153	CcSEcCtD
Vandetanib—Pain—Dexamethasone—asthma	2.68e-05	0.000153	CcSEcCtD
Vandetanib—Nervous system disorder—Prednisone—asthma	2.68e-05	0.000153	CcSEcCtD
Vandetanib—Skin disorder—Prednisone—asthma	2.65e-05	0.000151	CcSEcCtD
Vandetanib—Asthenia—Hydrocortisone—asthma	2.63e-05	0.00015	CcSEcCtD
Vandetanib—Pruritus—Hydrocortisone—asthma	2.6e-05	0.000148	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dexamethasone—asthma	2.57e-05	0.000146	CcSEcCtD
Vandetanib—Gastrointestinal pain—Betamethasone—asthma	2.57e-05	0.000146	CcSEcCtD
Vandetanib—Diarrhoea—Hydrocortisone—asthma	2.51e-05	0.000143	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Prednisone—asthma	2.49e-05	0.000142	CcSEcCtD
Vandetanib—Dizziness—Prednisolone—asthma	2.49e-05	0.000142	CcSEcCtD
Vandetanib—Asthenia—Triamcinolone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Body temperature increased—Betamethasone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Abdominal pain—Betamethasone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Body temperature increased—Dexamethasone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Abdominal pain—Dexamethasone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Asthenia—Methylprednisolone—asthma	2.48e-05	0.000141	CcSEcCtD
Vandetanib—Insomnia—Prednisone—asthma	2.47e-05	0.000141	CcSEcCtD
Vandetanib—Paraesthesia—Prednisone—asthma	2.45e-05	0.00014	CcSEcCtD
Vandetanib—Pruritus—Triamcinolone—asthma	2.45e-05	0.000139	CcSEcCtD
Vandetanib—Pruritus—Methylprednisolone—asthma	2.44e-05	0.000139	CcSEcCtD
Vandetanib—Dizziness—Hydrocortisone—asthma	2.43e-05	0.000138	CcSEcCtD
Vandetanib—Dyspepsia—Prednisone—asthma	2.41e-05	0.000137	CcSEcCtD
Vandetanib—Decreased appetite—Prednisone—asthma	2.38e-05	0.000135	CcSEcCtD
Vandetanib—Rash—Prednisolone—asthma	2.37e-05	0.000135	CcSEcCtD
Vandetanib—Dermatitis—Prednisolone—asthma	2.37e-05	0.000135	CcSEcCtD
Vandetanib—Diarrhoea—Methylprednisolone—asthma	2.36e-05	0.000134	CcSEcCtD
Vandetanib—Fatigue—Prednisone—asthma	2.36e-05	0.000134	CcSEcCtD
Vandetanib—Headache—Prednisolone—asthma	2.36e-05	0.000134	CcSEcCtD
Vandetanib—Constipation—Prednisone—asthma	2.34e-05	0.000133	CcSEcCtD
Vandetanib—Vomiting—Hydrocortisone—asthma	2.34e-05	0.000133	CcSEcCtD
Vandetanib—Rash—Hydrocortisone—asthma	2.32e-05	0.000132	CcSEcCtD
Vandetanib—Dermatitis—Hydrocortisone—asthma	2.31e-05	0.000132	CcSEcCtD
Vandetanib—Headache—Hydrocortisone—asthma	2.3e-05	0.000131	CcSEcCtD
Vandetanib—Dizziness—Triamcinolone—asthma	2.29e-05	0.00013	CcSEcCtD
Vandetanib—Dizziness—Methylprednisolone—asthma	2.28e-05	0.00013	CcSEcCtD
Vandetanib—Asthenia—Betamethasone—asthma	2.25e-05	0.000128	CcSEcCtD
Vandetanib—Asthenia—Dexamethasone—asthma	2.25e-05	0.000128	CcSEcCtD
Vandetanib—Gastrointestinal pain—Prednisone—asthma	2.23e-05	0.000127	CcSEcCtD
Vandetanib—Nausea—Prednisolone—asthma	2.23e-05	0.000127	CcSEcCtD
Vandetanib—Pruritus—Betamethasone—asthma	2.22e-05	0.000126	CcSEcCtD
Vandetanib—Pruritus—Dexamethasone—asthma	2.22e-05	0.000126	CcSEcCtD
Vandetanib—Vomiting—Triamcinolone—asthma	2.2e-05	0.000125	CcSEcCtD
Vandetanib—Vomiting—Methylprednisolone—asthma	2.19e-05	0.000125	CcSEcCtD
Vandetanib—Nausea—Hydrocortisone—asthma	2.18e-05	0.000124	CcSEcCtD
Vandetanib—Rash—Triamcinolone—asthma	2.18e-05	0.000124	CcSEcCtD
Vandetanib—Dermatitis—Triamcinolone—asthma	2.18e-05	0.000124	CcSEcCtD
Vandetanib—Rash—Methylprednisolone—asthma	2.18e-05	0.000124	CcSEcCtD
Vandetanib—Dermatitis—Methylprednisolone—asthma	2.17e-05	0.000124	CcSEcCtD
Vandetanib—Headache—Triamcinolone—asthma	2.17e-05	0.000123	CcSEcCtD
Vandetanib—Headache—Methylprednisolone—asthma	2.16e-05	0.000123	CcSEcCtD
Vandetanib—Abdominal pain—Prednisone—asthma	2.16e-05	0.000123	CcSEcCtD
Vandetanib—Body temperature increased—Prednisone—asthma	2.16e-05	0.000123	CcSEcCtD
Vandetanib—Diarrhoea—Betamethasone—asthma	2.15e-05	0.000122	CcSEcCtD
Vandetanib—Diarrhoea—Dexamethasone—asthma	2.15e-05	0.000122	CcSEcCtD
Vandetanib—Dizziness—Betamethasone—asthma	2.07e-05	0.000118	CcSEcCtD
Vandetanib—Dizziness—Dexamethasone—asthma	2.07e-05	0.000118	CcSEcCtD
Vandetanib—Nausea—Triamcinolone—asthma	2.05e-05	0.000117	CcSEcCtD
Vandetanib—Nausea—Methylprednisolone—asthma	2.05e-05	0.000117	CcSEcCtD
Vandetanib—Vomiting—Dexamethasone—asthma	1.99e-05	0.000114	CcSEcCtD
Vandetanib—Vomiting—Betamethasone—asthma	1.99e-05	0.000114	CcSEcCtD
Vandetanib—Rash—Dexamethasone—asthma	1.98e-05	0.000113	CcSEcCtD
Vandetanib—Rash—Betamethasone—asthma	1.98e-05	0.000113	CcSEcCtD
Vandetanib—Dermatitis—Dexamethasone—asthma	1.98e-05	0.000112	CcSEcCtD
Vandetanib—Dermatitis—Betamethasone—asthma	1.98e-05	0.000112	CcSEcCtD
Vandetanib—Headache—Dexamethasone—asthma	1.97e-05	0.000112	CcSEcCtD
Vandetanib—Headache—Betamethasone—asthma	1.97e-05	0.000112	CcSEcCtD
Vandetanib—Asthenia—Prednisone—asthma	1.96e-05	0.000112	CcSEcCtD
Vandetanib—Pruritus—Prednisone—asthma	1.93e-05	0.00011	CcSEcCtD
Vandetanib—Diarrhoea—Prednisone—asthma	1.87e-05	0.000106	CcSEcCtD
Vandetanib—Nausea—Betamethasone—asthma	1.86e-05	0.000106	CcSEcCtD
Vandetanib—Nausea—Dexamethasone—asthma	1.86e-05	0.000106	CcSEcCtD
Vandetanib—Dizziness—Prednisone—asthma	1.81e-05	0.000103	CcSEcCtD
Vandetanib—Vomiting—Prednisone—asthma	1.74e-05	9.89e-05	CcSEcCtD
Vandetanib—Rash—Prednisone—asthma	1.72e-05	9.81e-05	CcSEcCtD
Vandetanib—Dermatitis—Prednisone—asthma	1.72e-05	9.8e-05	CcSEcCtD
Vandetanib—Headache—Prednisone—asthma	1.71e-05	9.74e-05	CcSEcCtD
Vandetanib—Nausea—Prednisone—asthma	1.62e-05	9.24e-05	CcSEcCtD
Vandetanib—PDGFRB—Signaling Pathways—IL6R—asthma	1.75e-06	1.12e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—VEGFA—asthma	1.75e-06	1.12e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—asthma	1.74e-06	1.12e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—LEP—asthma	1.74e-06	1.12e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SMAD3—asthma	1.73e-06	1.12e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—STAT3—asthma	1.73e-06	1.11e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—POMC—asthma	1.73e-06	1.11e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—ALB—asthma	1.73e-06	1.11e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—STAT3—asthma	1.72e-06	1.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—asthma	1.72e-06	1.11e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—EGFR—asthma	1.72e-06	1.11e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CCL2—asthma	1.72e-06	1.1e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—PTEN—asthma	1.72e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—asthma	1.71e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—asthma	1.71e-06	1.1e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6R—asthma	1.71e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—asthma	1.71e-06	1.1e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—MMP9—asthma	1.7e-06	1.1e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—VEGFA—asthma	1.7e-06	1.1e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTGS2—asthma	1.7e-06	1.09e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PTEN—asthma	1.69e-06	1.09e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CCL2—asthma	1.69e-06	1.09e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—STAT3—asthma	1.69e-06	1.09e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—STAT3—asthma	1.69e-06	1.08e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6R—asthma	1.68e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—VEGFA—asthma	1.68e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—STAT3—asthma	1.68e-06	1.08e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—LEP—asthma	1.67e-06	1.08e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—STAT3—asthma	1.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALOX5AP—asthma	1.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALOX15—asthma	1.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—POMC—asthma	1.67e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—STAT3—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—SERPINE1—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PPP2CA—asthma	1.66e-06	1.07e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—BCL2—asthma	1.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—NOS3—asthma	1.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—asthma	1.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—asthma	1.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—MMP9—asthma	1.65e-06	1.06e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—asthma	1.64e-06	1.06e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—asthma	1.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—FN1—asthma	1.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—PTGS2—asthma	1.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—SERPINE1—asthma	1.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PTEN—asthma	1.64e-06	1.05e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCR5—asthma	1.63e-06	1.05e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—PTEN—asthma	1.61e-06	1.03e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTEN—asthma	1.6e-06	1.03e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2RA—asthma	1.6e-06	1.03e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TGFB1—asthma	1.6e-06	1.03e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—SERPINE1—asthma	1.6e-06	1.03e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—RHOA—asthma	1.6e-06	1.03e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—VEGFA—asthma	1.59e-06	1.03e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—STAT3—asthma	1.59e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—C3—asthma	1.59e-06	1.02e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CHAT—asthma	1.59e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS3—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTP1—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—RHOA—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—FN1—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—SERPINE1—asthma	1.58e-06	1.02e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—PTEN—asthma	1.57e-06	1.01e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—EGFR—asthma	1.57e-06	1.01e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—EGFR—asthma	1.57e-06	1.01e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—NOS3—asthma	1.56e-06	1.01e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TGFB1—asthma	1.56e-06	1.01e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—HMOX1—asthma	1.56e-06	1e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—ITPR1—asthma	1.56e-06	1e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PDGFB—asthma	1.55e-06	9.97e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTEN—asthma	1.55e-06	9.95e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—RHOA—asthma	1.55e-06	9.95e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TGFB1—asthma	1.55e-06	9.95e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CAT—asthma	1.54e-06	9.91e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—STAT3—asthma	1.53e-06	9.87e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—EGFR—asthma	1.53e-06	9.87e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—EGFR—asthma	1.53e-06	9.86e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—NOS3—asthma	1.53e-06	9.84e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—EGFR—asthma	1.53e-06	9.83e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—RHOA—asthma	1.52e-06	9.79e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—ALB—asthma	1.52e-06	9.77e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—EGFR—asthma	1.52e-06	9.75e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—STAT3—asthma	1.51e-06	9.75e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—EGFR—asthma	1.51e-06	9.72e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTGS2—asthma	1.51e-06	9.72e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—NOS3—asthma	1.51e-06	9.69e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—POMC—asthma	1.49e-06	9.6e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—PTEN—asthma	1.48e-06	9.54e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—LEP—asthma	1.48e-06	9.54e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—VEGFA—asthma	1.48e-06	9.51e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TGFB1—asthma	1.48e-06	9.49e-06	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—asthma	1.47e-06	9.45e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—STAT3—asthma	1.46e-06	9.42e-06	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—TGFB1—asthma	1.46e-06	9.41e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—asthma	1.46e-06	9.4e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—asthma	1.46e-06	9.4e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CCL2—asthma	1.46e-06	9.39e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—asthma	1.46e-06	9.37e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6R—asthma	1.46e-06	9.37e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PLA2G4A—asthma	1.45e-06	9.36e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—GSTM1—asthma	1.45e-06	9.36e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—NOS3—asthma	1.45e-06	9.35e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTGS2—asthma	1.45e-06	9.33e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—EGFR—asthma	1.45e-06	9.31e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—POMC—asthma	1.44e-06	9.25e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—STAT3—asthma	1.44e-06	9.24e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—PTEN—asthma	1.43e-06	9.19e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—TGFB1—asthma	1.42e-06	9.15e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALOX5—asthma	1.42e-06	9.12e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CCL2—asthma	1.41e-06	9.05e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—STAT3—asthma	1.41e-06	9.05e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TGFB1—asthma	1.4e-06	9.04e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6R—asthma	1.4e-06	9.03e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—FN1—asthma	1.4e-06	8.99e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—EGFR—asthma	1.39e-06	8.97e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—CXCL8—asthma	1.39e-06	8.92e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—STAT3—asthma	1.38e-06	8.9e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—EGFR—asthma	1.38e-06	8.86e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTEN—asthma	1.37e-06	8.81e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—SERPINE1—asthma	1.36e-06	8.77e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—CXCL8—asthma	1.36e-06	8.73e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TGFB1—asthma	1.36e-06	8.73e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CARM1—asthma	1.35e-06	8.7e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PPP2CA—asthma	1.34e-06	8.62e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—CXCL8—asthma	1.34e-06	8.6e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DCN—asthma	1.33e-06	8.57e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—EGFR—asthma	1.33e-06	8.56e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTGS2—asthma	1.33e-06	8.55e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—STAT3—asthma	1.33e-06	8.53e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—asthma	1.32e-06	8.52e-06	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—asthma	1.32e-06	8.5e-06	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—PTEN—asthma	1.32e-06	8.47e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—RHOA—asthma	1.31e-06	8.46e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—SERPINE1—asthma	1.31e-06	8.45e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TGFB1—asthma	1.3e-06	8.39e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—NOS3—asthma	1.3e-06	8.37e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—asthma	1.3e-06	8.35e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALDH2—asthma	1.3e-06	8.34e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—EGFR—asthma	1.28e-06	8.22e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—STAT3—asthma	1.28e-06	8.22e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—asthma	1.28e-06	8.22e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—POMC—asthma	1.27e-06	8.19e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—RHOA—asthma	1.27e-06	8.15e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—PTEN—asthma	1.26e-06	8.14e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—EGFR—asthma	1.26e-06	8.09e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—NOS3—asthma	1.25e-06	8.07e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—MMP9—asthma	1.25e-06	8.07e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTEN—asthma	1.25e-06	8.02e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CCL2—asthma	1.25e-06	8.01e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6R—asthma	1.24e-06	7.99e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTT1—asthma	1.23e-06	7.93e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—TGFB1—asthma	1.23e-06	7.91e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—MMP9—asthma	1.23e-06	7.9e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—STAT3—asthma	1.22e-06	7.88e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTEN—asthma	1.22e-06	7.85e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—MMP9—asthma	1.21e-06	7.78e-06	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—asthma	1.21e-06	7.78e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—asthma	1.2e-06	7.75e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTEN—asthma	1.2e-06	7.73e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—TGFB1—asthma	1.18e-06	7.62e-06	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—asthma	1.18e-06	7.59e-06	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—asthma	1.18e-06	7.58e-06	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—asthma	1.17e-06	7.55e-06	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—asthma	1.16e-06	7.49e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—SERPINE1—asthma	1.16e-06	7.48e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—EGFR—asthma	1.16e-06	7.47e-06	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—asthma	1.16e-06	7.47e-06	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—PTEN—asthma	1.16e-06	7.46e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—CXCL8—asthma	1.15e-06	7.43e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—STAT3—asthma	1.13e-06	7.28e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—VEGFA—asthma	1.13e-06	7.24e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—RHOA—asthma	1.12e-06	7.22e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—STAT3—asthma	1.11e-06	7.17e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—EGFR—asthma	1.11e-06	7.16e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—CXCL8—asthma	1.11e-06	7.16e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—asthma	1.11e-06	7.15e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—NOS3—asthma	1.11e-06	7.14e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—asthma	1.1e-06	7.1e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—VEGFA—asthma	1.1e-06	7.09e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—asthma	1.1e-06	7.06e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—STAT3—asthma	1.09e-06	7.02e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—VEGFA—asthma	1.08e-06	6.98e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—STAT3—asthma	1.07e-06	6.91e-06	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—asthma	1.07e-06	6.9e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—asthma	1.06e-06	6.84e-06	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—asthma	1.06e-06	6.81e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—TGFB1—asthma	1.05e-06	6.75e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—MMP9—asthma	1.04e-06	6.72e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTEN—asthma	1.04e-06	6.68e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TGFB1—asthma	1.03e-06	6.65e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—POMC—asthma	1.03e-06	6.61e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—EGFR—asthma	1.03e-06	6.61e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NQO1—asthma	1.02e-06	6.59e-06	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—asthma	1.02e-06	6.58e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—EGFR—asthma	1.01e-06	6.52e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TGFB1—asthma	1.01e-06	6.51e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—MMP9—asthma	1.01e-06	6.47e-06	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—asthma	1e-06	6.45e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ADCY2—asthma	1e-06	6.45e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTEN—asthma	1e-06	6.44e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TGFB1—asthma	9.96e-07	6.41e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—EGFR—asthma	9.92e-07	6.38e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—CXCL8—asthma	9.84e-07	6.34e-06	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—asthma	9.82e-07	6.32e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—EGFR—asthma	9.76e-07	6.28e-06	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—asthma	9.66e-07	6.22e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—asthma	9.41e-07	6.06e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—VEGFA—asthma	9.37e-07	6.03e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—STAT3—asthma	9.28e-07	5.97e-06	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—asthma	9.26e-07	5.96e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—VEGFA—asthma	9.03e-07	5.81e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—NOS3—asthma	8.96e-07	5.77e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—STAT3—asthma	8.94e-07	5.76e-06	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—asthma	8.92e-07	5.74e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—MMP9—asthma	8.9e-07	5.73e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTEN—asthma	8.85e-07	5.7e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TGFB1—asthma	8.6e-07	5.54e-06	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—asthma	8.55e-07	5.51e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTP1—asthma	8.54e-07	5.5e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HMOX1—asthma	8.42e-07	5.42e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ITPR1—asthma	8.4e-07	5.41e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CAT—asthma	8.31e-07	5.35e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TGFB1—asthma	8.29e-07	5.34e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTGS2—asthma	8.2e-07	5.28e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—EGFR—asthma	8.13e-07	5.23e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—VEGFA—asthma	8e-07	5.15e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—STAT3—asthma	7.92e-07	5.1e-06	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—asthma	7.9e-07	5.08e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PLA2G4A—asthma	7.85e-07	5.05e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—GSTM1—asthma	7.85e-07	5.05e-06	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—asthma	7.78e-07	5.01e-06	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—asthma	7.62e-07	4.91e-06	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—asthma	7.5e-07	4.83e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TGFB1—asthma	7.34e-07	4.72e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PPP2CA—asthma	7.23e-07	4.65e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—EGFR—asthma	7.2e-07	4.63e-06	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PTEN—asthma	7.15e-07	4.6e-06	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—asthma	6.48e-07	4.17e-06	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—asthma	6.25e-07	4.02e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—POMC—asthma	5.55e-07	3.57e-06	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—asthma	5.53e-07	3.56e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—ALB—asthma	5.06e-07	3.26e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—NOS3—asthma	4.84e-07	3.11e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTGS2—asthma	4.43e-07	2.85e-06	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PTEN—asthma	3.86e-07	2.48e-06	CbGpPWpGaD
